Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity
about
Herpesvirus gB: A Finely Tuned Fusion MachineThe immunological underpinnings of vaccinations to prevent cytomegalovirus disease.A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.Immunization in Canada: Update for 2015.Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.The history of vaccination against cytomegalovirus.Cytomegalovirus Vaccines: Current Status and Future Prospects.Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1+ NK cells.Cytomegalovirus vaccines under clinical developmentRMCE-based insect cell platform to produce membrane proteins captured on HIV-1 Gag virus-like particles.Enveloped virus-like particle platforms: vaccines of the future?Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections.Fine-mapping the interaction between DC-SIGN and the cytomegalovirus envelope glycoprotein B.
P2860
Q26774203-B6F2F452-33A0-4DFF-8B17-77E591A8682FQ27692570-329BF6A0-A381-4FB7-AFA0-7214E2E5A103Q36385141-16DCE347-462E-44C7-AF98-8CEA87B9E414Q36728581-38DCB9A4-C94E-4DE0-93DC-E63C51A0A2CFQ37409233-0BAA893F-BDEF-46FF-B738-D72A17FD7A89Q38384533-1603DA37-D268-4976-8C33-2D9F1353D37CQ38791353-168F80D9-6D12-4130-8C19-F834A1E5FB02Q40467077-F0F1DCA3-BE40-46FE-A5E5-0FC553E011F7Q42380888-DB67A1B2-0A2C-4FE0-A61D-86ADD4282CC4Q45324767-24FBD516-0F53-4286-84C8-DCC1FFE26170Q45342129-69055A04-5B1B-432A-9B13-72B1501AB64BQ47115255-3875F31A-06BD-491D-A57D-FCF314DF5FD7Q47546281-6F82FC01-9D5E-4F47-8F38-D44A037B678FQ52323814-28356D2C-FA2D-4146-8254-0F99A6633A98
P2860
Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enveloped virus-like particle ...... nd broad neutralizing activity
@en
Enveloped virus-like particle ...... d broad neutralizing activity.
@nl
type
label
Enveloped virus-like particle ...... nd broad neutralizing activity
@en
Enveloped virus-like particle ...... d broad neutralizing activity.
@nl
prefLabel
Enveloped virus-like particle ...... nd broad neutralizing activity
@en
Enveloped virus-like particle ...... d broad neutralizing activity.
@nl
P2093
P2860
P356
P1476
Enveloped virus-like particle ...... nd broad neutralizing activity
@en
P2093
Abebaw Diress
Anne-Catherine Fluckiger
Barthelemy Ontsouka
Catalina Soare
Charlotte Dalba
David E Anderson
David Klatzmann
Florian Schödel
Jasminka Bozic
Lenore Pereira
P2860
P304
P356
10.1128/CVI.00662-13
P577
2013-12-11T00:00:00Z